drugset / Trial / NCT00397670
Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm
Phase 2/3
Completed
200 enrolled
ReProtect Inc
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabPremier Research · collab
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to study the safety and contraceptive effectiveness of BufferGel used with a contraceptive diaphragm.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BufferGel | Unknown | — | — |
Indications
No indication recorded.